Your browser doesn't support javascript.
loading
Effects of escalating doses of recombinant human interleukin-2 in correcting functional T-cell defects following autologous bone marrow transplantation for lymphomas and solid tumors.
Bosly, A; Guillaume, T; Brice, P; Humblet, Y; Staquet, P; Doyen, C; Chatelain, B; Franks, C R; Gisselbrecht, C; Symann, M.
Affiliation
  • Bosly A; Experimental Oncology and Hematology Laboratory, Catholic University of Louvain, Brussels, Belgium.
Exp Hematol ; 20(8): 962-8, 1992 Sep.
Article in En | MEDLINE | ID: mdl-1354620
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Recombinant Proteins / T-Lymphocytes / Choriocarcinoma / Bone Marrow Transplantation / Interleukin-2 / Carcinoma, Small Cell / Lung Neoplasms / Lymphoma Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Exp Hematol Year: 1992 Type: Article Affiliation country: Belgium
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Recombinant Proteins / T-Lymphocytes / Choriocarcinoma / Bone Marrow Transplantation / Interleukin-2 / Carcinoma, Small Cell / Lung Neoplasms / Lymphoma Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Exp Hematol Year: 1992 Type: Article Affiliation country: Belgium